Literature DB >> 26962392

Periorbital Hyperpigmentation: A Comprehensive Review.

Rashmi Sarkar1, Rashmi Ranjan1, Shilpa Garg1, Vijay K Garg1, Sidharth Sonthalia1, Shivani Bansal1.   

Abstract

Periorbital hyperpigmentation is a commonly encountered condition. There is very little scientific data available on the clinical profile and pathogenesis of periorbital hyperpigmentation. Periorbital hyperpigmentation is caused by various exogenous and endogenous factors. The causative factors include genetic or heredity, excessive pigmentation, postinflammatory hyperpigmentation secondary to atopic and allergic contact dermatitis, periorbital edema, excessive vascularity, shadowing due to skin laxity and tear trough associated with aging. There are a number of treatment options available for periorbital hyperpigmentation. Among the available alternatives to treat dark circles are topical depigmenting agents, such as hydroquinone, kojic acid, azelaic acid, and topical retinoic acid, and physical therapies, such as chemical peels, surgical corrections, and laser therapy, most of which are tried scientifically for melasma, another common condition of hyperpigmentation that occurs on the face. The aim of treatment should be to identify and treat the primary cause of hyperpigmentation as well as its contributing factors.

Entities:  

Year:  2016        PMID: 26962392      PMCID: PMC4756872     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  41 in total

1.  Management of infraorbital dark circles. A significant cosmetic concern.

Authors:  J S Epstein
Journal:  Arch Facial Plast Surg       Date:  1999 Oct-Dec

2.  Acquired bilateral nevus of Ota-like macules mimicking dark circles under the eyes.

Authors:  Suhyun Cho; Sang Ju Lee; Won Soon Chung; Jin Moon Kang; Young Koo Kim; Sung Bin Cho
Journal:  J Cosmet Laser Ther       Date:  2010-06       Impact factor: 2.247

3.  Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles.

Authors:  Charitomeni Vavouli; Andreas Katsambas; Stamatis Gregoriou; Anca Teodor; Carmen Salavastru; Adina Alexandru; George Kontochristopoulos
Journal:  J Cosmet Dermatol       Date:  2013-09       Impact factor: 2.696

4.  The safety of hydroquinone.

Authors:  James Nordlund; Pearl Grimes; Jean-Paul Ortonne
Journal:  J Cosmet Dermatol       Date:  2006-06       Impact factor: 2.696

5.  Condition known as "dark rings under the eyes" in the Japanese population is a kind of dermal melanocytosis which can be successfully treated by Q-switched ruby laser.

Authors:  Shinichi Watanabe; Kenji Nakai; Takamitsu Ohnishi
Journal:  Dermatol Surg       Date:  2006-06       Impact factor: 3.398

6.  Clinical course of bimatoprost-induced periocular skin changes in Caucasians.

Authors:  Manali Doshi; Deepak P Edward; Smajo Osmanovic
Journal:  Ophthalmology       Date:  2006-08-28       Impact factor: 12.079

7.  Periorbital melanosis is an extension of pigmentary demarcation line-F on face.

Authors:  Subrata Malakar; Koushik Lahiri; Uttam Banerjee; S Mondal; S Sarangi
Journal:  Indian J Dermatol Venereol Leprol       Date:  2007 Sep-Oct       Impact factor: 2.545

8.  Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.

Authors:  Ian L Guevara; Amit G Pandya
Journal:  Int J Dermatol       Date:  2003-12       Impact factor: 2.736

9.  Periorbital hyperpigmentation and erythema dyschromicum perstans.

Authors:  E B Ing; J R Buncic; B A Weiser; J de Nanassy; L Boxall
Journal:  Can J Ophthalmol       Date:  1992-12       Impact factor: 1.882

10.  A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients.

Authors:  Rashmi Sarkar; Mala Bhalla; Amrinder J Kanwar
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

View more
  12 in total

Review 1.  [Pathophysiology of atopic blepharokeratoconjunctivitis].

Authors:  T Lapp; P Maier; T Jakob; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

2.  Effectiveness and Safety of Topical Under-eye Serum in Patients with Periorbital Hyperpigmentation: An Open-label Single Arm Prospective Study.

Authors:  B S Chandrashekar; Soragavi Soumya
Journal:  J Clin Aesthet Dermatol       Date:  2022-02

3.  A Prospective Trial of the Microneedle Fractional Radiofrequency System Application in the Treatment of Infraorbital Dark Circles.

Authors:  Xianglei Wu; Ying Liu; Jiafang Zhu; Wenxin Yu; Xiaoxi Lin
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-08

4.  Periorbital Rejuvenation: A Study on the Use of Dermal Threads as Monotherapy, with a Review of Literature.

Authors:  Gulhima Arora; Sandeep Arora
Journal:  J Cutan Aesthet Surg       Date:  2022 Jan-Mar

5.  Periorbital Hyperpigmentation: What Lies Beneath?

Authors:  Rashmi Sarkar; Anupam Das
Journal:  Indian Dermatol Online J       Date:  2018 Jul-Aug

6.  Study of Causative Factors and Clinical Patterns of Periorbital Pigmentation.

Authors:  Vibhu Mendiratta; Shiwangi Rana; Rubina Jassi; Ram Chander
Journal:  Indian Dermatol Online J       Date:  2019 May-Jun

7.  Global periorbital skin rejuvenation by a topical eye cream containing low molecular weight heparan sulfate (LMW-HS) and a blend of naturally derived extracts.

Authors:  Lora Colvan; Tina Fleck; Virginia L Vega
Journal:  J Cosmet Dermatol       Date:  2019-01-12       Impact factor: 2.696

8.  Periocular Dark Circles: Correlates of Severity.

Authors:  Hester Gail Y Lim; Alexander H Fischer; Sarah Sung; Sewon Kang; Anna L Chien
Journal:  Ann Dermatol       Date:  2021-09-08       Impact factor: 1.444

9.  A Study of Clinicopathological Correlation of Periorbital Hyperpigmentation.

Authors:  Chitra S Nayak; Atul S Giri; Uddhao S Zambare
Journal:  Indian Dermatol Online J       Date:  2018 Jul-Aug

10.  Identification Of Three Key Factors Contributing To The Aetiology Of Dark Circles By Clinical And Instrumental Assessments Of The Infraorbital Region.

Authors:  Sophie Mac-Mary; Itziar Zornoza Solinis; Océane Predine; Jean-Marie Sainthillier; Christelle Sladen; Mike Bell; Mark O'Mahony
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.